AFC-HD AMS Life Science Co., Ltd. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Nov'25

Aug'25

May'25

Feb'25

Nov'24

Aug'24

May'24

Net Sales

8,547.59

7,917.22

8,123.45

8,424.49

8,189.86

7,841.40

7,801.07

Other Operating Income

0.00

Total Operating income

8,547.59

7,917.22

8,123.45

8,424.49

8,189.86

7,841.40

7,801.07

Raw Material Cost

5,583.32

5,222.95

5,353.64

5,663.52

5,444.86

5,281.73

5,247.23

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

54.01

58.39

57.64

47.61

37.58

32.90

28.86

Selling and Distribution Expenses

2,192.67

2,138.17

2,211.18

2,116.92

2,094.16

2,102.44

2,045.21

Other Expenses

-5.40

-5.84

-5.76

-4.76

-3.76

0.39

0.75

Total Expenditure (Excl Depreciation)

7,775.99

7,361.12

7,564.82

7,780.43

7,539.02

7,420.92

7,328.82

Operating Profit (PBDIT) excl Other Income

771.5999999999999

556.1

558.6

644.0999999999999

650.8

420.5

472.2

Other Income

25.59

69.68

23.95

26.91

90.76

50.66

6.10

Operating Profit (PBDIT)

1,138.52

980.82

941.17

1,021.30

1,074.88

741.15

767.35

Interest

54.01

58.39

57.64

47.61

37.58

32.90

28.86

Exceptional Items

23.62

-486.23

207.27

61.37

-1.11

-15.70

5.00

Gross Profit (PBDT)

2,964.27

2,694.27

2,769.81

2,760.98

2,745.00

2,559.68

2,553.84

Depreciation

341.34

355.04

358.60

350.33

333.28

270.02

289.01

Profit Before Tax

766.79

81.16

732.21

684.73

702.90

422.53

454.49

Tax

247.13

83.53

187.13

224.07

237.48

100.10

173.06

Provisions and contingencies

0.00

Profit After Tax

522.59

36.08

531.00

421.34

460.12

329.25

281.22

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

522.59

36.08

531.00

421.34

460.12

329.25

281.22

Share in Profit of Associates

0.00

Minority Interest

-2.92

-38.46

14.08

39.32

5.31

-6.82

0.21

Other related items

0.00

Consolidated Net Profit

519.66

-2.38

545.08

460.66

465.43

322.43

281.43

Equity Capital

0.00

Face Value

0.0

Reserves

15,556.29

15,076.46

14,920.74

14,638.17

14,199.80

13,933.84

13,673.96

Earnings per share (EPS)

36.7

2.56

37.77

29.95

32.69

23.39

19.97

Diluted Earnings per share

36.7

2.56

37.77

29.95

32.69

23.39

19.97

Operating Profit Margin (Excl OI)

9.03%

7.02%

6.88%

7.65%

7.95%

5.36%

6.05%

Gross Profit Margin

12.96%

5.51%

13.43%

12.29%

12.65%

8.83%

9.53%

PAT Margin

6.11%

0.46%

6.54%

5.0%

5.62%

4.2%

3.6%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Nov 2025 is 4.37% vs 20.68% in Nov 2024

Consolidate Net Profit

YoY Growth in quarter ended Nov 2025 is 11.67% vs 45.71% in Nov 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Nov 2025 is 13.09% vs 35.89% in Nov 2024

Interest

YoY Growth in quarter ended Nov 2025 is 43.62% vs 113.64% in Nov 2024

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Nov 2025 has improved from Nov 2024

Compare Quarterly Results Of AFC-HD AMS Life Science Co., Ltd. With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(JPY)

Change(%)

Net Sales

8,547.59

2,516.80

6,030.79

239.62%

Other Operating Income

0.00

Total Operating income

8,547.59

2,516.80

6,030.79

239.62%

Raw Material Cost

5,583.32

659.68

4,923.64

746.37%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

54.01

6.15

47.86

778.21%

Selling and Distribution Expenses

2,192.67

2,737.94

-545.27

-19.92%

Other Expenses

-5.40

-0.61

-4.79

-785.25%

Total Expenditure (Excl Depreciation)

7,775.99

3,397.62

4,378.37

128.87%

Operating Profit (PBDIT) excl Other Income

771.59

-880.82

1,652.41

187.60%

Other Income

25.59

3.07

22.52

733.55%

Operating Profit (PBDIT)

1,138.52

-871.63

2,010.15

230.62%

Interest

54.01

6.15

47.86

778.21%

Exceptional Items

23.62

12.51

11.11

88.81%

Gross Profit (PBDT)

2,964.27

1,857.12

1,107.15

59.62%

Depreciation

341.34

6.12

335.22

5,477.45%

Profit Before Tax

766.79

-871.39

1,638.18

188.00%

Tax

247.13

-266.60

513.73

192.70%

Provisions and contingencies

0.00

Profit After Tax

522.59

-604.79

1,127.38

186.41%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

522.59

-604.79

1,127.38

186.41%

Share in Profit of Associates

0.00

Minority Interest

-2.92

0.00

-2.92

Other related items

0.00

Consolidated Net Profit

519.66

-604.79

1,124.45

185.92%

Equity Capital

0.00

Face Value

0.00

Reserves

15,556.29

669.08

14,887.21

2,225.03%

Earnings per share (EPS)

36.70

-65.52

102.22

156.01%

Diluted Earnings per share

36.70

-65.52

102.22

156.01%

Operating Profit Margin (Excl OI)

9.03%

-35.00%

0.00

44.03%

Gross Profit Margin

12.96%

-34.38%

0.00

47.34%

PAT Margin

6.11%

-24.03%

0.00

30.14%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 854.76 Million

in Nov 2025

Figures in Million

QoQ Growth in quarter ended Nov 2025 is 7.96% vs -2.54% in Aug 2025

YoY Growth in quarter ended Nov 2025 is 4.37% vs 20.68% in Nov 2024

Quarterly - Consolidate Net Profit

Consolidate Net Profit 51.97 Million

in Nov 2025

Figures in Million

QoQ Growth in quarter ended Nov 2025 is 21,754.17% vs -100.44% in Aug 2025

YoY Growth in quarter ended Nov 2025 is 11.67% vs 45.71% in Nov 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 111.29 Million

in Nov 2025

Figures in Million

QoQ Growth in quarter ended Nov 2025 is 22.15% vs -0.67% in Aug 2025

YoY Growth in quarter ended Nov 2025 is 13.09% vs 35.89% in Nov 2024

Quarterly - Interest

Interest 5.40 Million

in Nov 2025

Figures in Million

QoQ Growth in quarter ended Nov 2025 is -7.53% vs 1.39% in Aug 2025

YoY Growth in quarter ended Nov 2025 is 43.62% vs 113.64% in Nov 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 9.03%

in Nov 2025

Figures in %

QoQ Growth in quarter ended Nov 2025 has improved from Aug 2025

YoY Growth in quarter ended Nov 2025 has improved from Nov 2024